ATTORNEY ADVERTISING

Have you experienced health problems while taking RAPTIVA? You may be entitled to compensation - but you need to act NOW!.

For Your FREE Consultation CALL NOW: 1-800-283-0026

Raptiva linked to risk of life-threatening infections

If you've been taking Raptiva to treat your psoriasis, you could be at risk for life-threatening infections leading to hospitalization and death. You may be entitled to compensation — but time could be running out. Statutes of limitations vary from state to state — which means that you should make your case NOW, before it's too late.

Raptiva (efalizumab) is a prescription drug approved in 2003 for the treatment of moderate to severe plaque psoriasis. Psoriasis is an inflammatory skin disease. Raptiva is administered by once-weekly, under-the-skin injection in adults who are candidates for systemic (whole body) therapy or phototherapy (light therapy) to control their psoriasis. It works by suppressing the immune system to reduce flare-ups of psoriasis.

Raptiva Pulled From the U.S. Market

In a statement released April 8, 2009 Genentech, the manufacturer of Raptiva, announced a voluntary, phased withdrawal of the drug from the U.S. market. Patients who have used Raptiva are at potential risk to develop progressive multifocal leukoencephalopathy (PML). PML is a rare but serious neurological disease caused by a virus that affects the central nervous system.

PML generally occurs in those people whose immune systems are severely weakened and often leads to an irreversible decline neurological function, eventually leading to death. At this point there is no known treatment for PML that is considered to be effective.

FDA Issues Black Box Warning for Raptiva

On October 16, 2008 the FDA announced a black box warning for Raptiva — the strongest warning a drug can receive — regarding the risk of serious, life-threatening infections including bacterial sepsis, viral meningitis, invasive fungal disease, progressive multifocal leukencephalopathy (PML) and other opportunistic infections.

Signs and Symptoms of Progressive Multifocal Leukoencephalopathy (PML)

PML is a rare, progressive disease of the central nervous system caused by the reactivation of a latent virus which results in progressive damage or inflammation of the brain. In a healthy adult, the virus usually stays dormant.  PML occurs almost exclusively in people with severe immune deficiency who are more susceptible to infection.

Signs and symptoms of Progressive Leukoencephalopathy (PML) may include:

If you've experienced health complications while taking Raptiva, it's time to get the justice you deserve — but you must act NOW. Call today.

For a FREE, no-obligation, legal consultation

CALL NOW: 1-800-283-0026

We can help!

Find out what to do next to get the justice you deserve by filling out this form or calling 1-800-283-0026 today.

UNDERSTAND YOUR RIGHTS

Get your FREE consultation

* Indicates a required field

Yes No

Yes No

Yes No

Sokolove Law, LLC

Sokolove Law's mission is to reinvent how people obtain legal services, in order to provide everyone, irrespective of ethnicity or income, equal access to our civil justice system and within it, superior quality of representation and service.